The company offers drug delivery technologies, surface modification coating technologies, and components for in vitro diagnostic test kits and specialized surfaces for cell culture and microarrays. With headquarters in Minnesota and a subsidiary in Alabama, SurModics is a global leader in surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. SurModics is committed to developing highly differentiated medical devices that address unmet clinical needs and meet demanding requirements.